Gene Expression Analysis of Glioblastomas and Age Impact on Survival
Author Information
Author(s): Lee Yohan, Scheck Adrienne C, Cloughesy Timothy F, Lai Albert, Dong Jun, Farooqi Haumith K, Liau Linda M, Horvath Steve, Mischel Paul S, Nelson Stanley F
Primary Institution: University of California Los Angeles
Hypothesis
Younger patients with glioblastomas have better survival rates due to a higher likelihood of having the ProNeural subtype.
Conclusion
The survival benefit of younger age is nullified when patients are stratified by gene expression group.
Supporting Evidence
- Younger patients with glioblastomas have a higher likelihood of having the ProNeural subtype.
- The ProNeural subtype is associated with longer survival compared to other subtypes.
- Age does not predict survival when controlling for tumor subtype.
Takeaway
Younger people with brain tumors called glioblastomas usually live longer, but this is because they often have a type of tumor that is less aggressive.
Methodology
The study analyzed gene expression data from 267 glioblastoma samples using microarray technology and statistical methods to assess survival differences.
Potential Biases
Potential biases may arise from demographic differences in patient populations and treatment variations.
Limitations
The study may be limited by the variability in treatment across institutions and the lack of clinical data for some samples.
Participant Demographics
239 patients with available age data, including 151 males and 88 females, aged 18 to 86.
Statistical Information
P-Value
4.9e-6
Confidence Interval
95% CI not specified
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website